Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2860485 | 0.80 | MEN1 (0.41) | CA1CA2 | |
| SCHEMBL29561529 | 0.80 | MEN1 (0.41) | CA1CA2 | |
| SCHEMBL7636146 | 0.80 | ALDH1A1 (0.34) | CA1CA2 | |
| SCHEMBL6533122 | 0.74 | NFE2L2 (0.47) | — | |
| SCHEMBL22669111 | 0.74 | — | — | |
| SCHEMBL277191 | 0.70 | CA1 (0.33) | CA1CA2 | |
| SCHEMBL1324313 | 0.68 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL277192 | 0.68 | BCL2L1 (0.39) | CA1CA2 | |
| SCHEMBL13374382 | 0.68 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL2783384 | 0.68 | CA1 (0.32) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101152185-B | Use of heterocyclic compounds as SCCE inhibitors | AREXIS AB | 2010-12-08 | — | — | CN | disclosed |
| CN-100518740-C | Pharmaceutical use of heterocyclic compounds as SCCE inhibitors | AREXIS AB (SE) | 2009-07-29 | — | — | CN | disclosed |
| CN-101152185-A | Use of heterocyclic compounds as scce inhibitors | AREXIS AB (SE) | 2008-04-02 | — | — | CN | disclosed |
| CN-1802160-A | Use of heterocyclic compounds as SCCE inhibitors | AREXIS AB (SE) | 2006-07-12 | — | — | CN | disclosed |